Australian Group on Antimicrobial Resistance (AGAR). Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2023. 2024. https://agargroup.org.au/agar-reports/
Duffy MA, Hernandez-Santiago V, Orange G, Davey PG, Guthrie B. Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis. Br J Gen Pract 2013;63(609):e238-43. https://www.ncbi.nlm.nih.gov/pubmed/23540479
Nelson Z, Tarik Aslan A, Beahm NP, Blyth M, Cappiello M, Casaus D, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open 2024;7(11):e2444495. https://www.ncbi.nlm.nih.gov/pubmed/39495518
Osthoff M, McGuinness SL, Wagen AZ, Eisen DP. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital. Int J Infect Dis 2015;34:79-83. https://pubmed.ncbi.nlm.nih.gov/25769526/
Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother 2001;47(6):781-7. https://pubmed.ncbi.nlm.nih.gov/11389110/